miR-429 modulates the expression of c-myc in human gastric carcinoma cells

Tiewei Sun1, Chunmei Wang, Jun Xing

  • 1Department of General Surgery, Second Affiliated Hospital of Harbin Medical University, Hei LongJiang, Harbin, China.

European Journal of Cancer (Oxford, England : 1990)
|June 21, 2011
PubMed
Abstract

Insights

MicroRNA-429 (miR-429) is downregulated in gastric cancer, inhibiting cell viability and proliferation. It targets c-myc, suggesting miR-429 acts as a tumor suppressor in gastric carcinoma progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Dysregulation of miRNAs is implicated in various cancers, including gastric cancer.
  • Investigating specific miRNAs like miR-429 is crucial for understanding cancer pathogenesis.

Purpose of the Study:

  • To investigate the role and regulation of miR-429 in gastric cancer.
  • To explore the underlying mechanisms of miR-429's influence on gastric cancer development.
  • To identify downstream targets of miR-429 in gastric cancer cells.

Main Methods:

  • Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for miR-429 expression analysis in patient tissues and cell lines.
  • Bioinformatic analysis to predict potential downstream target genes of miR-429.
  • Luciferase reporter assays and Western blot analysis to validate miR-429 targets and their functional impact on gene expression (e.g., c-myc).

Main Results:

  • miR-429 expression was significantly downregulated in gastric cancer tissues and cells compared to normal tissues.
  • Transfection with miR-429 mimics reduced cell viability, proliferation, and attachment in gastric cancer cells.
  • miR-429 was confirmed to directly target the 3' untranslated region (3'UTR) of the c-myc gene, leading to decreased c-myc expression.
  • Lower miR-429 levels correlated with lymph node metastasis in gastric cancer patients.

Conclusions:

  • miR-429 functions as a tumor suppressor in gastric carcinoma, playing a role in its pathogenesis.
  • c-myc is identified as a key downstream target gene of miR-429 in gastric cancer.
  • The downregulation of miR-429 may contribute to gastric cancer progression and metastasis.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...